JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation is allowed to use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website for educational purpose only. Bodily introduction of any kind into humans and animals is strictly forbidden by law. This product should only be handled by licenced qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused as a drug, food and cosmetic.
FREE Shipping for orders over $200
For this product you will need: BACTERIOSTATIC WATER For reconstitution.
CJC-1295 is a synthetic modification of growth hormone-releasing hormone (GHRH) and in the first 29 amino acids of the peptide chain. It's the molecule that attaches to GHRH receptors in the pituitary and stimulates release of growth hormone.
CJC-1295 is comprised of 29 amino acids and was originally developed by ConjuChem Technologies in the mid-2000s as part of a program focused on peptide stability and molecular persistence characteristics. Compared to native GHRH, CJC-1295 exhibits altered degradation kinetics, making it of interest in laboratory investigations involving peptide half-life assessment, molecular modification strategies, and signalling pathway architecture studies. CJC-1295 No DAC available on our website is supplied exclusively to educational and research institutions for laboratory use only and is not intended for human or animal consumption or medical application.
From Pubchem
Synonyms: CJC1295 Without DACMolecular Formula: C152H252N44O42Molecular Weight: 3367.9 g/molSequence: YADAXFXQSYRKVLAQLSARKLLQDXLSRPubChem CID: 91976842
CJC-1295 is a synthetic peptide analog derived from the growth hormone–releasing hormone (GHRH) sequence family and is referenced in scientific literature for the examination of peptide modification strategies, receptor-binding models, and sequence–structure relationships within controlled research environments [1]. Experimental investigations involving CJC-1295 have primarily focused on comparative molecular analysis, signal pathway mapping, and transcriptional interaction frameworks using non-clinical research systems [2].
Due to specific structural modifications, CJC-1295 has been included in studies exploring peptide stability parameters, molecular persistence characteristics, and exposure-duration modeling under laboratory-controlled conditions. Additional research efforts have examined its pharmacokinetic and pharmacodynamic profiles from an analytical standpoint, with emphasis on distribution modeling, temporal activity patterns, and peptide interaction behavior rather than functional or therapeutic outcomes [3].
CJC-1295 is a synthetic analog of GHRH with modifications in the first 29 amino acids of the sequence. It was developed to create a longer-acting GHRH analog. Limited research has been conducted on this molecule. At Element CRP, CJC-1295 no DAC purchase is restricted to educational and research purposes. Only buy CJC-1295 no DAC if you are a licensed researcher.
CJC-1295 (without DAC), also known as Modified GRF 1-29, is a synthetic 29-amino-acid peptide analogue of GHRH containing four amino acid substitutions designed to improve stability against enzymatic degradation. Its modified structure supports reproducible activity in standard cell culture buffer systems used for receptor pharmacology research.
Cell-based research with CJC-1295 No DAC characterises engagement at the GHRH receptor using transfected cell line backgrounds and primary pituitary cell preparations. Functional assays measure Gas/cAMP coupling, downstream PKA-mediated phosphorylation events, and transcriptional activation through CREB-responsive reporter gene constructs.
Element CRP supplies this product at 2mg per vial. USA-manufactured via solid-phase peptide synthesis and verified at 99%+ purity by HPLC and Mass Spectrometry. Reconstitution with bacteriostatic water required. Store lyophilised at -20°C; stable for 24 months.
WARNING: For research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease. For use by qualified research professionals only.
Forgot password?
Country: United States (US-only registration)
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
Element CRP is a chemical supplier. Element CRP is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Element CRP is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
